Benitec Biopharma Inc (BNTC)
10.66
+0.26
(+2.50%)
USD |
NASDAQ |
Nov 15, 16:00
10.66
0.00 (0.00%)
After-Hours: 16:55
Benitec Biopharma Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | |
| December 31, 2019 |
| Date | Value |
|---|---|
| September 30, 2019 | |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | |
| June 30, 2015 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Jun 2020
--
Maximum
Jun 2020
--
Average
--
Median
Jun 2020
Debt to Equity Ratio Benchmarks
| NovaBay Pharmaceuticals Inc | 0.0476 |
| Palatin Technologies Inc | 0.00 |
| iBio Inc | 0.0461 |
| Theriva Biologics Inc | -- |
| Oragenics Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 52.21M |
| Total Liabilities (Quarterly) | 4.962M |
| Shareholders Equity (Quarterly) | 47.25M |